Cargando…

Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan

Second-line Helicobacter pylori (H. pylori) eradication with fluoroquinolone-containing triple therapy is one of the recommended treatment options, but neither 7-day nor 10-day regimens provide >90% success rates. The current retrospective study aimed to clarify the effects of 10-day and 14-day l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tai, Wei-Chen, Chiu, Chien-Hua, Liang, Chih-Ming, Chang, Kuo-Chin, Kuo, Chung-Mou, Chiu, Yi-Chun, Wu, Keng-Liang, Hu, Ming-Luen, Chou, Yeh-Pin, Chiou, Shue-Shian, Chiu, King-Wah, Kuo, Chung-Huang, Hu, Tsung-Hui, Lin, Ming-Tsung, Chuah, Seng-Kee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819765/ https://www.ncbi.nlm.nih.gov/pubmed/24235968 http://dx.doi.org/10.1155/2013/932478

Ejemplares similares

The Clinical and Bacteriological Factors for Optimal Levofloxacin-Containing Triple Therapy in Second-Line Helicobacter pylori Eradication
por: Tai, Wei-Chen, et al.
Publicado: (2014)

A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication
por: Chuah, Seng-Kee, et al.
Publicado: (2016)

Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication
por: Tai, Wei-Chen, et al.
Publicado: (2015)

First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan
por: Liang, Chih-Ming, et al.
Publicado: (2017)

Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis
por: Liang, Chih-Ming, et al.
Publicado: (2012)

Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
por: Huang, Hsiang Tso, et al.
Publicado: (2018)

Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
por: Hung, Kuo-Tung, et al.
Publicado: (2021)

Quinolone-Containing Therapies in the Eradication of Helicobacter pylori
por: Chuah, Seng-Kee, et al.
Publicado: (2014)

Outcome of Holiday and Nonholiday Admission Patients with Acute Peptic Ulcer Bleeding: A Real-World Report from Southern Taiwan
por: Wu, Tsung-Chin, et al.
Publicado: (2014)

The efficacy of limited endoscopic sphincterotomy plus endoscopic papillary large balloon dilation for removal of large bile duct stones
por: Kuo, Chung-Mou, et al.
Publicado: (2019)

Levofloxacin-Amoxicillin/Clavulanate-Rabeprazole versus a Standard Seven-Day Triple Therapy for Eradication of Helicobacter pylori Infection
por: Chen, Ming-Cheh, et al.
Publicado: (2014)

The effects of endoscopic-guided balloon dilations in esophageal and gastric strictures caused by corrosive injuries
por: Chiu, Yi-Chun, et al.
Publicado: (2013)

Novel Low-Cost Endoscopic Cap for Esophageal Foreign Objects: A Case Report
por: Chiu, King-Wah, et al.
Publicado: (2015)

A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial
por: Tai, Wei-Chen, et al.
Publicado: (2019)

Endosonographic surveillance of 1-3 cm gastric submucosal tumors originating from muscularis propria
por: Hu, Ming-Luen, et al.
Publicado: (2017)

Comparison of argon plasma coagulation in management of upper gastrointestinal angiodysplasia and gastric antral vascular ectasia hemorrhage
por: Chiu, Yi-Chun, et al.
Publicado: (2012)

Endoscopic Management of Foreign Bodies in the Upper Gastrointestinal Tract of Adults
por: Yao, Chih-Chien, et al.
Publicado: (2015)

Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
por: Azab, Eman T., et al.
Publicado: (2022)

First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus
por: Yao, Chih-Chien, et al.
Publicado: (2019)

Endoscopic Biopsy as Quality Assurance for Endoscopic Services
por: Chiu, King-Wah, et al.
Publicado: (2013)

Association between Helicobacter pylori eradication and the risk of coronary heart diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2018)

Surveillance cultures of samples obtained from biopsy channels and automated endoscope reprocessors after high-level disinfection of gastrointestinal endoscopes
por: Chiu, King-Wah, et al.
Publicado: (2012)

Limited precut sphincterotomy combined with endoscopic papillary balloon dilation for common bile duct stone removal in patients with difficult biliary cannulation
por: Kuo, Chung-Mou, et al.
Publicado: (2016)

Seven‐day vonoprazan‐based triple therapy as first‐line Helicobacter pylori treatment in comparison with extended sequential therapy
por: Chiu, Yu‐Tse, et al.
Publicado: (2023)

Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication
por: Eisig, Jaime N, et al.
Publicado: (2009)

A comparison between non-sedation and general endotracheal anesthesia for retrograde endoscopic common bile duct stone removal: A tertiary center experience
por: Liang, Chih-Ming, et al.
Publicado: (2019)

Comparison of Levofloxacin-Based, 10-day Sequential Therapy with 14-day Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial
por: Hajiani, Eskandar, et al.
Publicado: (2018)

Early and Direct Endoscopic Stone Removal in the Moderate Grade of Acute Cholangitis with Choledocholithiasis Was Safe and Effective: A Prospective Study
por: Liang, Chih-Ming, et al.
Publicado: (2022)

Efficacy and safety of 7 days versus 10 days triple therapy based on levofloxacin-dexlansoprazole for eradication of Helicobacter pylori: A pilot randomized trial
por: Elkhodary, Noha Mahmoud, et al.
Publicado: (2020)

The Association of Helicobacter pylori Eradication with the Occurrences of Chronic Kidney Diseases in Patients with Peptic Ulcer Diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2016)

The Clinical Presentations of Liver Abscess Development After Endoscopic Retrograde Cholangiopancreatography with Choledocholithiasis: A 17-Year Follow-Up
por: Liu, An-Che, et al.
Publicado: (2023)

The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naïve Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial
por: Tai, Wei-Chen, et al.
Publicado: (2023)

Eradication of Helicobacter pylori Is Associated with the Progression of Dementia: A Population-Based Study
por: Chang, Yang-Pei, et al.
Publicado: (2013)

Telbivudine and adefovir combination therapy for patients with chronic lamivudine-resistant hepatitis B virus infections
por: Lin, Ming-Tsung, et al.
Publicado: (2013)

Decreased Gastric Motility in Type II Diabetic Patients
por: Chiu, Yi-Chun, et al.
Publicado: (2014)

Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial
por: Liou, Jyh-Ming, et al.
Publicado: (2016)

Ten-day tegoprazan-based concomitant therapy as a first-line treatment for Helicobacter pylori eradication
por: Kwon, Yong Hwan, et al.
Publicado: (2023)

Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease
por: Kuo, Ming-Te, et al.
Publicado: (2015)

The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance
por: Huang, Tzu-Hsin, et al.
Publicado: (2021)

Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal Study
por: Tsai, Ming-Chao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gr6nvsdrrrkit1li97c9f4m1pu